ADCT ADC Therapeutics SA

ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.

$8.02  +0.13 (1.65%)
As of 06/27/2022 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  Switzerland
IPO date:  05/15/2020
Outstanding shares:  76,810,477
Average volume:  299,407
Market cap:   $528,456,082
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   -3.11
PB ratio:   3.73
PS ratio:   6.57
Return on equity:   -119.98%
Net income %:   -242.69%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy